BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 17488404)

  • 21. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sunburn and p53 in the onset of skin cancer.
    Ziegler A; Jonason AS; Leffell DJ; Simon JA; Sharma HW; Kimmelman J; Remington L; Jacks T; Brash DE
    Nature; 1994 Dec 22-29; 372(6508):773-6. PubMed ID: 7997263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.
    Ren ZP; Hedrum A; Pontén F; Nistér M; Ahmadian A; Lundeberg J; Uhlén M; Pontén J
    Oncogene; 1996 Feb; 12(4):765-73. PubMed ID: 8632898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of dysregulated genes in cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Manning K; O'Currain E; Schneider S; Sterry W; Stockfleth E; Nindl I
    Oncol Rep; 2006 Sep; 16(3):513-9. PubMed ID: 16865251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
    Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
    Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
    Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
    Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
    Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
    Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the INK4a locus in squamous cell carcinomas of human skin.
    Kubo Y; Urano Y; Matsumoto K; Ahsan K; Arase S
    Biochem Biophys Res Commun; 1997 Mar; 232(1):38-41. PubMed ID: 9125147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
    Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
    Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
    Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
    Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
    Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
    Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
    Greer RO; Meyers A; Said SM; Shroyer KR
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.